The Quantellect read.As of Nov 19, 2026, 5 active firms cover GeneDx Holdings Corp: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $63.00 to $90.00, a moderate spread. The average target of $80.20 sits 54% above the current $51.99. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.01 next quarter toward $1.30 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$80.20
+54.3% upside
Average target across 5 active firms as of Nov 19, 2026 vs $51.99 current
Highest Target$90.00
Average Target$80.20
Lowest Target$63.00
Detailed analyst forecasts for WGS
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate WGS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
WGS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.01
Range $-0.16 – $0.10 · 3 analysts · -98% YoY
Next period, 3 analysts expect GeneDx Holdings Corp. to earn $-0.01 a share (range $-0.16 – $0.10), versus $-0.28 a year earlier. Full-year consensus is $0.42, growing to $1.30 the year after.
REVENUE · NEXT QUARTER
$122.9M
Range $115.3M – $130.7M · 3 analysts · +20% YoY
Revenue is expected to reach $122.9M (range $115.3M – $130.7M), +20.2% year-over-year. Full-year consensus is $476.3M, rising to $569.7M next year.
Top analysts covering GeneDx Holdings Corp.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WGS.
#1
KM
Kyle Mikson
Canaccord Genuity · Rank #202
Buy
$90.00+73.1% to target
Overall win rate
40%
+ Follow
#2
Mark Massaro
BTIG · Rank #220
Buy
$85.00+63.5% to target
Overall win rate
44%
+ Follow
#3
David Westenberg
Piper Sandler · Rank #314
Buy
$63.00+21.2% to target
Overall win rate
35%
+ Follow
#4
Matthew Sykes
Goldman Sachs · Rank #352
Neutral
$80.00+53.9% to target
Overall win rate
38%
+ Follow
#5
Subbu Nambi
Guggenheim
Buy
$83.00+59.6% to target
Coverage
—
+ Follow
WGS stock forecast FAQ
What is WGS's average 12-month price target?+
The 5 active firms with a live target average $80.20 for GeneDx Holdings Corp. over the next 12 months, ranging from a $90.00 high to a $63.00 low, as of Nov 19, 2026.
Is WGS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for WGS?+
The Street-high target is $90.00 (Canaccord Genuity), and the Street-low is $63.00 (Piper Sandler). The average of all 5 active-firm targets is $80.20.
How many active Wall Street firms cover WGS?+
5 active firms have a recognized rating on GeneDx Holdings Corp. as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering WGS?+
Among analysts who currently cover WGS, Kyle Mikson of Canaccord Genuity has the strongest overall Quantellect track record (Rank #202). Their current call is Buy with a $90.00 target.
What is GeneDx Holdings Corp.'s projected EPS for next quarter?+
The consensus estimate is $-0.01 per share (range $-0.16 – $0.10) across 3 analysts. Full-year EPS is projected at $0.42, rising to $1.30 the following year.
How much revenue is GeneDx Holdings Corp. expected to report next quarter?+
Consensus revenue is $122.9M (range $115.3M – $130.7M). Full-year revenue is projected at $476.3M, growing to $569.7M next year.
Have analysts been upgrading or downgrading WGS lately?+
As of Nov 19, 2026, 5 of 5 active firms rate WGS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WGS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.